Erratum: A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract (PLoS Computational Biology (2020) 16:4 (e1007705) DOI: 10.1371/journal.pcbi.1007705);A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract

PLoS Computational Biology

Volumn 16, Issue 4, 2020, Pages

  Quirouette, Christian ^a   Younis, Nada P ^a   Reddy, Micaela B ^b   Beauchemin, Catherine A A ^a,c  

^a RYERSON UNIVERSITY   (Canada)

^b ARRAY BIOPHARMA INC   (United States)

^c RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVECTION; DIFFUSION; MAMMALS; TISSUE REGENERATION;

CILIATED CELLS; COMPUTATIONAL BIOLOGY; HUMAN RESPIRATORY TRACT; IN-VIVO; INFLUENZA A VIRUS; LOCALISATION; MUCUS LAYER; ONE-DIMENSIONAL; STATIONARY CELLS; VIRUS INFECTION;

VIRUSES;

ANTIVIRUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; CELL REGENERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INFLUENZA A; LOWER RESPIRATORY TRACT INFECTION; MATHEMATICAL MODEL; MOUSE; NONHUMAN; RESPIRATORY SYSTEM; SEASONAL INFLUENZA; TISSUE INJURY; TISSUE LEVEL; UPPER RESPIRATORY TRACT INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; INFLUENZA; INFLUENZA A VIRUS; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; THEORETICAL MODEL; VIROLOGY; VIRUS REPLICATION;

HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MODELS, THEORETICAL; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY SYSTEM; VIRUS REPLICATION;

EID: 85084025190     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1008424     Document Type: Erratum

References (89)

1. Dobrovolny HM, Reddy MB, Kamel MA, Rayner CR, Beauchemin CAA. Assessing mathematical models of influenza infections using features of the immune response. PLoS One. 2013; 8(2):e57088. https://doi.org/10.1371/journal.pone.0057088 PMID: 23468916
2. Boianelli A, Nguyen VK, Ebensen T, Schulze K, Wilk E, Sharma N, et al. Modeling influenza virus infection: A roadmap for influenza research. Viruses. 2015; 7(10):5274–5304. https://doi.org/10.3390/ v7102875 PMID: 26473911
3. Handel A, Liao LE, Beauchemin CAA. Progress and trends in mathematical modelling of influenza A virus infections. Curr Opin Syst Biol. 2018; 12:30–36. https://doi.org/10.1016/j.coisb.2018.08.009
4. Strain MC, Richman DD, Wong JK, Levine H. Spatiotemporal dynamics of HIV propagation. J Theor Biol. 2002; 218(1):85–96. https://doi.org/10.1006/jtbi.2002.3055 PMID: 12297072
5. Beauchemin C, Samuel J, Tuszynski J. A simple cellular automaton model for influenza A viral infections. J Theor Biol. 2005; 232(2):223–234. https://doi.org/10.1016/j.jtbi.2004.08.001 PMID: 15530492
6. Beauchemin C. Probing the effects of the well-mixed assumption on viral infection dynamics. J Theor Biol. 2006; 242(2):464–477. https://doi.org/10.1016/j.jtbi.2006.03.014 PMID: 16650441
7. Bauer AL, Beauchemin CAA, Perelson AS. Agent-based modeling of host-pathogen systems: The successes and challenges. Inform Sciences. 2009; 179(10):1379–1389. https://doi.org/10.1016/j.ins.2008.11.012
8. Mitchell H, Levin D, Forrest S, Beauchemin CAA, Tipper J, Knight J, et al. Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: Kinetics from epithelial cell culture and computational modeling. J Virol. 2011; 85(2):1125–1135. https://doi.org/10.1128/JVI.01722-10 PMID: 21068247
9. Reperant LA, Kuiken T, Grenfell BT, Osterhaus ADME, Dobson AP. Linking influenza virus tissue tropism to population-level reproductive fitness. PLoS One. 2012; 7(8):e43115. https://doi.org/10.1371/journal.pone.0043115 PMID: 22952637
10. Gallagher ME, Brooke CB, Ke R, Koelle K. Causes and consequences of spatial within-host viral spread. Viruses. 2018; 10(11):627. https://doi.org/10.3390/v10110627
11. Fahy JV, Dickey BF. Airway Mucus Function and Dysfunction. N Engl J Med. 2010; 363(23):2233–2247. https://doi.org/10.1056/NEJMra0910061 PMID: 21121836
12. Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol. 2017; 9(4):a028241. https://doi.org/10.1101/cshperspect.a028241 PMID: 27864314
13. Hussong J, Lindken R, Faulhammer P, Noreikat K, Sharp K, Kummer W, et al. Cilia-driven particle and fluid transport over mucus-free mice tracheae. J Biomech. 2013; 46(3):593–598. https://doi.org/10.1016/j.jbiomech.2012.08.020 PMID: 23276626
14. Bermbach S, Weinhold K, Roeder T, Petersen F, Kugler C, Goldmann T, et al. Mechanisms of cilia-driven transport in the airways in the absence of mucus. Am J Respir Cell Mol Biol. 2014; 51(1):56–67. https://doi.org/10.1165/rcmb.2012-0530OC PMID: 24467665
15. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, García-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci USA. 2010; 107(25):11531–11536. https://doi.org/10.1073/pnas.0914994107 PMID: 20534532
16. Tran V, Moser LA, Poole DS, Mehle A. Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J Virol. 2013; 87(24):13321–13329. https://doi.org/10.1128/JVI.02381-13 PMID: 24089552
17. Bocharov GA, Romanyukha AA. Mathematical model of antiviral immune response III. Influenza A virus infection. J Theor Biol. 1994; 167(4):323–360. https://doi.org/10.1006/jtbi.1994.1074 PMID: 7516024
18. Peiris JSM, de Jong MD, Guan Y. Avian influenza virus (H5N1): A threat to human health. Clin Microbiol Rev. 2007; 20(2):243–267. https://doi.org/10.1128/CMR.00037-06 PMID: 17428885
19. Raabe OG, Yeh HC, Schum GM, Phalen RF. Tracheobronchial geometry: Human, dog, rat, hamster. Lovelace Foundation; 1976.
20. Stoneham MD. The nasopharyngeal airway. Assessment of position by fibreoptic laryngoscopy. Anaesthesia. 1993; 48(7):575–580. https://doi.org/10.1111/j.1365-2044.1993.tb07119.x PMID: 8346770
21. Paradis EG, Pinilla LT, Holder BP, Abed Y, Boivin G, Beauchemin CAA. Impact of the H275Y and I223V mutations in the neuraminidase of the 2009 pandemic influenza virus in vitro and evaluating experimental reproducibility. PLoS One. 2015; 10(5):e0126115. https://doi.org/10.1371/journal.pone. 0126115 PMID: 25992792
22. Simon PF, de La Vega MA, Paradis E, Mendoza E, Coombs KM, Kobasa D, et al. Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses. Sci Rep. 2016; 6:24154. https://doi.org/10.1038/srep24154 PMID: 27080193
23. Pinilla LT, Holder BP, Abed Y, Boivin G, Beauchemin CAA. The H275Y neuraminidase mutation of the pandemic A/H1N1 virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets. J Virol. 2012; 86(19):10651–10660. https://doi.org/10.1128/JVI. 07244-11 PMID: 22837199
24. Holder BP, Beauchemin CAA. Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture. BMC Public Health. 2011; 11(Suppl 1):S10. https://doi.org/10.1186/1471-2458-11-S1-S10 PMID: 21356129
25. Holder BP, Liao LE, Simon P, Boivin G, Beauchemin CAA. Design considerations in building in silico equivalents of common experimental influenza virus assays. Autoimmunity. 2011; 44(4). https://doi.org/10.3109/08916934.2011.523267 PMID: 21244331
26. Beauchemin C, Forrest S, Koster FT. Modeling influenza viral dynamics in tissue. In: Bersini H, Carneiro J, editors. Proceedings of the 5th International Conference on Artificial Immune Systems (ICARIS 06). No. 4163 in Lecture Notes in Computer Science. Springer-Verlag Berlin Heidelberg; 2006. p. 23–36.
27. Matsui H, Randell SH, Peretti SW, Davis CW, Boucher RC. Coordinated clearance of periciliary liquid and mucus from airway surfaces. J Clin Invest. 1998; 102(6):1125–1131. https://doi.org/10.1172/ JCI2687 PMID: 9739046
28. Yang S, Lee GWM, Chen CM, Wu CC, Yu KP. The size and concentration of droplets generated by coughing in human subjects. J Aerosol Med. 2007; 20(4):484–494. https://doi.org/10.1089/jam.2007. 0610 PMID: 18158720
29. Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. Kinetics of influenza A virus infection in humans. J Virol. 2006; 80(15):7590–7599. https://doi.org/10.1128/JVI.01623-05 PMID: 16840338
30. Chan MC, Chan RW, Yu WC, Ho CC, Chiu W, Lo C, et al. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir Res. 2009; 10(1). https://doi.org/10.1186/1465-9921-10-102 PMID: 19874627
31. Mora R, Rodriguez-Boulan E, Palese P, García-Sastre A. Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J Virol. 2002; 76 (7):3544–3553. https://doi.org/10.1128/JVI.76.7.3544-3553.2002 PMID: 11884578
32. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002; 109(5):571–577. https://doi.org/10.1172/JCI15217 PMID: 11877463
33. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies. Am J Epidemiol. 2008; 167 (7):775–785. https://doi.org/10.1093/aje/kwm375 PMID: 18230677
34. Balasingam S, Wilder-Smith A. Randomized controlled trials for influenza drugs and vaccines: A review of controlled human infection studies. Int J Infect Dis. 2016; 49:18–29. https://doi.org/10.1016/j.ijid.2016.05.013 PMID: 27208631
35. Ramphal R, Fischlschweiger W, Shands JW Jr, Small PA Jr. Murine influenzal tracheitis: A model for the study of influenza and tracheal epithelial repair. Am Rev Respir Dis. 1979; 120(6):1313–1324. PMID: 517860
36. Keenan KP, Wilson TS, McDowell EM. Regeneration of hamster tracheal epithelium after mechanical injury. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983; 43(3):213–240. https://doi.org/10.1007/ bf02932958 PMID: 6194612
37. Erjefält JS, Erjefält I, Sundler F, Persson CGA. In vivo restitution of airway epithelium. Cell Tissue Res. 1995; 281(2):305–316. https://doi.org/10.1007/bf00583399 PMID: 7648624
38. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010; 298(6):L715–L731. https://doi.org/10.1152/ajplung.00361.2009 PMID: 20363851
39. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA. 2009; 106(31):12771–12775. https://doi.org/10.1073/pnas.0906850106 PMID: 19625615
40. Hancioglu B, Swigon D, Clermont G. A dynamical model of human immune response to influenza A virus infection. J Theor Biol. 2010; 246(1):70–86. https://doi.org/10.1016/j.jtbi.2006.12.015
41. Cao P, Yan AWC, Heffernan JM, Petrie S, Moss RG, Carolan LA, et al. Innate immunity and the inter-exposure interval determine the dynamics of secondary influenza virus infection and explain observed viral hierarchies. PLoS Comput Biol. 2015; 11(8):e1004334. https://doi.org/10.1371/journal.pcbi. 1004334 PMID: 26284917
42. Cao P, McCaw JM. The mechanisms for within-host influenza virus control affect model-based assessment and prediction of antiviral treatment. Viruses. 2017; 9(8):E197. https://doi.org/10.3390/v9080197 PMID: 28933757
43. Fritz RS, Hayden FG, Calfee DP, Cass LMR, Peng AW, Alvord WG, et al. Nasal cytokine and chemo-kine response in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis. 1999; 180(3):586–593. https://doi.org/10.1086/314938 PMID: 10438343
44. Saenz RA, Quinlivan M, Elton D, MacRae S, Blunden AS, Mumford JA, et al. Dynamics of influenza virus infection and pathology. J Virol. 2010; 84(8):3974–3983. https://doi.org/10.1128/JVI.02078-09 PMID: 20130053
45. Iwasaki T, Nozima T. Defense mechanisms against primary influenza virus infection in mice. I. The Roles of Interferon and Neutralizing Antibodies and Thymus Dependence of Interferon and Antibody Production. J Immunol. 1977; 118(1):256–263. PMID: 401512
46. Hoshino A, Takenaka H, Mizukoshi O, Imanishi J, Kishida T, Tovey MG. Effect Of Anti-Interferon Serum Of Influenza Virus Infection In Mice. Antiviral Res. 1983; 3(1):59–65. https://doi.org/10.1016/ 0166-3542(83)90015-3 PMID: 6191656
47. Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, Mosmann TR, Perelson AS, et al. Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus. J Virol. 2010; 84(13):6687–6698. https://doi.org/10.1128/JVI.00266-10 PMID: 20410284
48. McLaren C, Butchko GM. Regional T- and B-cell responses in influenza-infected ferrets. Infect Immun. 1978; 22(1):189–194. https://doi.org/10.1128/IAI.22.1.189-194.1978 PMID: 365744
49. Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014; 14(5):315–328. https://doi.org/10.1038/nri3665 PMID: 24762827
50. Huang Y, Dai H, Ke R. Principles of robust innate immune response to viral infections: a multiplex network analysis. Front Immunol. 2019; 10:1736. https://doi.org/10.3389/fimmu.2019.01736 PMID: 31396233
51. Domingo-Calap P, Segredo-Otero E, Durán-Moreno M, Sanjuán R. Social evolution of innate immunity evasion in a virus. Nat Microbiol. 2019; 4(6):1006. https://doi.org/10.1038/s41564-019-0379-8 PMID: 30833734
52. Handel A, Longini IM, Antia R. Towards a quantitative understanding of the within-host dynamics of influenza A infections. J R Soc Interface. 2010; 7(42):35–47. https://doi.org/10.1098/rsif.2009.0067 PMID: 19474085
53. Lee HY, Topham DJ, Park SY, Hollenbaugh J, Treanor J, Mosmann TR, et al. Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol. 2009; 83(14):7151–7165. https://doi.org/10.1128/JVI.00098-09 PMID: 19439465
54. Wu T, Guan J, Handel A, Tscharke DC, Sidney J, Sette A, et al. Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses. Nat Commun. 2019; 10 (1):2846. https://doi.org/10.1038/s41467-019-10661-8 PMID: 31253788
55. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat, Med. 2002; 8(9):950–954. https://doi.org/10.1038/nm757
56. Yap KL, Ada GL. Cytotoxic T cells in the lungs of mice infected with an influenza A virus. Scand J Immunol. 1978; 7(1):73–80. https://doi.org/10.1111/j.1365-3083.1978.tb00428.x PMID: 305613
57. Wells MA, Albrecht P, Ennis FA. Recovery from a viral respiratory infection: 1. Influenza pneumonia in normal and T-deficient mice. J Immunol. 1981; 126(3):1036–1041. PMID: 6970211
58. Kris RM, Yetter RA, Cogliano R, Ramphal R, Small PA. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. Immunology. 1988; 63(3):349–353. PMID: 2832312
59. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJD, Chau TNB, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006; 12 (10):1203–1207. https://doi.org/10.1038/nm1477 PMID: 16964257
60. Cheung CY, Poon LLM, Lau AS, Luk W, Lau YL, Shortridge KF, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease? Lancet. 2002; 360(9348):1831–1837. https://doi.org/10.1016/s0140-6736(02)11772-7 PMID: 12480361
61. Chan M, Cheung C, Chui W, Tsao S, Nicholls J, Chan Y, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005; 6(1):135. https://doi.org/10.1186/1465-9921-6-135 PMID: 16283933
62. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: Influenza virus receptors in the human airway. Nature. 2006; 440(7083):435–436. https://doi.org/10.1038/440435a PMID: 16554799
63. Thompson CI, Barclay WS, Zambon MC, Pickles RJ. Infection of human airway epithelium by human and avian strains of influenza A virus. J Virol. 2006; 80(16):8060–8068. https://doi.org/10.1128/JVI. 00384-06 PMID: 16873262
64. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, et al. H5N1 virus attachment to lower respiratory tract. Science. 2006; 312(5772):399. https://doi.org/10.1126/science.1125548 PMID: 16556800
65. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol. 2007; 171(4):1215–1223. https://doi.org/10.2353/ajpath.2007.070248 PMID: 17717141
66. Hsieh SM, Chang SC. Insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol. 2006; 176(8):4530–4533. https://doi.org/10.4049/jimmunol.176.8.4530 PMID: 16585542
67. Petrie SM, Guarnaccia T, Laurie KL, Hurt AC, McVernon J, McCaw JM. Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load. PLoS One. 2013; 8(5):e64098. https://doi.org/10.1371/journal.pone.0064098 PMID: 23691157
68. Hayden FG, Tunkel AR, Treanor JJ, Betts RF, Allerheiligen S, Harris J. Oral LY217896 for Prevention of Experimental Influenza A Virus Infection and Illness in Humans. Antimicrob Agents Chemother. 1994; 38(5):1178–1181. https://doi.org/10.1128/aac.38.5.1178 PMID: 8067760
69. Reuman PD, Bernstein DI, Keefer MC, Young EC, Sherwood JR, Schiff GM. Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antivir Res. 1989; 11(1):27–40. https://doi.org/10.1016/0166-3542(89)90018-1 PMID: 2712549
70. Hien TT, Liem NT, Dung NT, San LT, Mai PP, van Vinh Chau N, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Eng J Med. 2004; 350(12):1179–1188. https://doi.org/10.1056/NEJMoa040419
71. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg infect Dis. 2005; 11(2):201–209. https://doi.org/10.3201/eid1102.041061 PMID: 15752436
72. Oner AF, Bay A, Arslan S, Akdeniz H, Sahin HA, Cesur Y, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med. 2006; 355(21):2179–2185. https://doi.org/10.1056/ NEJMoa060601 PMID: 17124015
73. Wang Z, Wan Y, Qiu C, Quinones-Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells. Nat Commun. 2015; 6:6833. https://doi.org/10.1038/ncomms7833 PMID: 25967273
74. Handel A, Longini IM Jr, Antia R. Neuraminidase inhibitor resistance in influenza: Assessing the danger of its generation and spread. PLoS Comput Biol. 2007; 3(12):e240. https://doi.org/10.1371/journal.pcbi. 0030240 PMID: 18069885
75. Dobrovolny HM, Baron MJ, Gieschke R, Davies BE, Jumbe NL, Beauchemin CAA. Exploring cell tropism as a possible contributor to influenza infection severity. PLoS One. 2010; 5(11):e13811. https://doi.org/10.1371/journal.pone.0013811 PMID: 21124892
76. Dobrovolny HM, Gieschke R, Davies BE, Jumbe NL, Beauchemin CAA. Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative study. J Theor Biol. 2011; 269(1):234–244. https://doi.org/10.1016/j.jtbi.2010.10.017 PMID: 20970433
77. Beggs NF, Dobrovolny HM. Determining drug efficacy parameters for mathematical models of influenza. J Biol Dyn. 2015; 9(sup1):332–346. https://doi.org/10.1080/17513758.2015.1052764 PMID: 26056712
78. Dobrovolny HM, Beauchemin CAA. Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms. PLoS One. 2017; 12(7):e0180582. https://doi.org/10.1371/journal.pone.0180582 PMID: 28700622
79. Liao LE, Kowal S, Cardenas DA, Beauchemin CAA. Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors. PLoS One. 2017; 12(8):e0183621. https://doi.org/10.1371/journal.pone.0183621 PMID: 28837615
80. Palmer J, Dobrovolny HM, Beauchemin CAA. The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients. Sci Rep. 2017; 7:40210. https://doi.org/10.1038/srep40210 PMID: 28067324
81. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA. 1996; 275(4):295–299. PMID: 8544269
82. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment. JAMA. 1999; 282(13):1240–1246. https://doi.org/10.1001/jama.282.13.1240 PMID: 10517426
83. Barroso L, Treanor J, Gubareva L, Hayden FG. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: Randomized, controlled trials for prophylaxis and treatment. Antivir Ther. 2005; 10(8):901–910. PMID: 16430195
84. Drake JW. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci USA. 1993; 90 (9):4171–4175. https://doi.org/10.1073/pnas.90.9.4171 PMID: 8387212
85. Perelson AS, Rong L, Hayden FG. Combination antiviral therapy for influenza: Predictions from modeling of human infections. J Infect Dis. 2012; 205(11):1642–1645. https://doi.org/10.1093/infdis/jis265 PMID: 22448006
86. Killingley B, Nguyen-Van-Tam J. Routes of influenza transmission. Influenza Other Respir Viruses. 2013; 7:42–51. https://doi.org/10.1111/irv.12080 PMID: 24034483
87. Carvalho TC, Peters JI, W RO III. Influence of pARTICLE size on regional lung deposition–what evidence is there? Int J Pharm. 2011; 406(1-2):1–10. https://doi.org/10.1016/j.ijpharm.2010.12.040 PMID: 21232585
88. Yan AWC, Zaloumis SG, Simpson JA, McCaw JM. Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection. PLoS Comput Biol. 2019; 15(1):e1006568. https://doi.org/10.1371/journal.pcbi.1006568 PMID: 30653522
89. Morton KW, Mayers DF. Numerical solution of partial differential equations: An introduction. 2nd ed. Cambridge, UK: Cambridge University Press; 2005.